11 results
424B5
ARCT
Arcturus Therapeutics Holdings Inc
30 Jul 20
Prospectus supplement for primary offering
6:01am
reputational damage for us and our technology platform going forward and other issues, including delays in our other programs, the need for re-design … vaccine candidate, we could incur liability, our competitive and reputational position could be harmed, and the further development and commercialization
424B5
ARCT
Arcturus Therapeutics Holdings Inc
28 Jul 20
Prospectus supplement for primary offering
4:17pm
of marketing approval. Unexpected safety issues could lead to significant reputational damage for us and our technology platform going forward and other issues … , including but not limited to information related to our LUNAR-COV19 vaccine candidate, we could incur liability, our competitive and reputational
10-K
z20h sx4dw
16 Mar 20
Annual report
11:09am
S-4
qbyx b08kv38hpxp
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
S-4/A
9wc9hnruf94uffxerf
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
424B3
9tmf1kem661spflmazyk
12 Apr 19
Prospectus supplement
4:39pm
- Prev
- 1
- Next